Absci Corp. (ABSI) PT Raised to $10 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
JPMorgan Double Downgrades Absci Corp. (ABSI) to Underweight
August 12, 2022 12:32 PM EDTJPMorgan analyst Tycho Peterson downgraded Absci Corp. (NASDAQ: ABSI) from Overweight to Underweight.
The analyst comments "ABSI offers an integrated drug creation platform that leverages proprietary synthetic biology technologies and deep learning AI to enable efficient discovery and development of novel protein-based drugs. The... More



